A Machine Learning/AI Cancer Rule-Out Test for the NHS Two Week Wait Pathway

NHS 两周等待途径的机器学习/人工智能癌症排除测试

• 批准号: 105411
• 金额: $ 43.86万
• 依托单位: PINPOINT DATA SCIENCE LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2019
• 资助国家: 英国
• 起止时间: 2019 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=105411
• 关键词: Machine; Learning; AI; Cancer; Rule

"The PinPoint Test is a machine learning/AI test that can rapidly 'rule out' cancer in patients referred by their GP for possible cancer diagnosis.93% of patients referred by their GP for possible diagnosis turn out to not have cancer. This is because of a 'safety first' approach that means most cancers are caught this way. However, it does mean several months of anxiety and unnecessary medical testing for those 93% of patients. And because those patients still have symptoms, it's important to find out what is wrong with them, even if it isn't cancer.The PinPoint Test helps identify the patients who don't have cancer, so that they can go back to their GP in days rather than months, once cancer is safely ruled out.This will also help the NHS a great deal. In 2018, 2.17 million patients in England were referred this way. This puts a huge strain on NHS cancer diagnostic services, and the PinPoint Test can reduce this number by over 500,000\. This will reduce pressure on NHS services, and free up clinicians to spend more time on the patients who do have cancer."

“PinPoint 测试是一种机器学习/人工智能测试，可以快速‘排除’全科医生转诊进行可能的癌症诊断的患者中的癌症。93% 的全科医生转诊进行可能的诊断的患者结果没有患有癌症。这是因为‘安全第一’的方法意味着大多数癌症都是通过这种方式发现的。然而，这确实意味着这 93% 的患者需要几个月的焦虑和不必要的医学检查。而且由于这些患者仍然有症状，因此重要的是要 找出他们的问题所在，即使不是癌症。PinPoint 测试有助于识别未患有癌症的患者，这样一旦癌症被安全排除，他们就可以在几天而不是几个月内去看全科医生。这也将为 NHS 带来很大帮助。 2018年，英格兰有217万名患者通过这种方式转诊。这给 NHS 癌症诊断服务带来了巨大压力，而 PinPoint Test 可以将这一数字减少超过 500,000 名。这将 reduce pressure on NHS services, and free up clinicians to spend more time on the patients who do have cancer."